Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 mars 2024 09h00 HE | Source: Er-Kim

Er-Kim Selected to Join the World Economic Forum’s New Champions Community

ATHENS, Greece, March 05, 2024 (GLOBE NEWSWIRE) -- Er-Kim, a pharmaceutical company specializing in the commercialization of novel therapies in international markets, announced today it has been...
08 janv. 2024 18h01 HE | Source: Er-Kim

Er-Kim Announces Exclusive Distribution Agreement with Ascendis Pharma A/S to Commercialize 3 Endocrinology Disease Treatments Across Central & Eastern Europe and Turkey

Er-Kim is appointed as the exclusive Ascendis A/S endocrinology distributor across Central & Eastern Europe and Turkey
24 nov. 2023 08h00 HE | Source: Er-Kim Pharmaceuticals

Er-Kim Pharmaceuticals Supports Worldwide Prevention of Antimicrobial Resistance (AMR)

Er-Kim Pharmaceuticals joins the industry to collaborate on the prevention of antimicrobial resistance (AMR) in support of World AMR Awareness Week